Home › Funds › Castleview Partners, LLC › ELV

Castleview Partners, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Castleview Partners, LLC reported holding 4,972 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.85% of its reported portfolio and ranking #25 among its reported holdings. Castleview Partners, LLC has disclosed ELV holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)4.97K sh
Reported value held$1.93M
Portfolio Weight0.85%
First reportedQ1 2024
Last changeAdd
Updated2026-10-10

Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR

How Castleview Partners, LLC's ELV position evolved

Castleview Partners, LLC first disclosed a stake in ELV in Q1 2024 at 2 shares (US$1K). The position peaked in Q3 2025 at 6,643 shares, worth US$2.1M. Across 10 filings, Castleview Partners, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,972 shares valued at US$1.9M — an increase of 269 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2025 (shares fell 10% over the following quarter), a 87% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2 $1.04K New
Q2 2024 2 $1.08K Hold
Q4 2024 2.33K $850.92K New
Q1 2025 3.17K $1.38M Add
Q2 2025 3.56K $1.38M Add
Q3 2025 6.64K $2.15M Add
Q4 2025 5.41K $1.90M Reduce
Q1 2026 5.06K $1.48M Reduce
Q2 2026 4.70K $1.82M Reduce
Q3 2026 4.97K $1.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Castleview Partners, LLC held ELV?

Castleview Partners, LLC has disclosed ELV holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

What is Castleview Partners, LLC's current position in ELV?

As of Q3 2026, Castleview Partners, LLC holds 4.97K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $1.93M, representing 0.85% of its reported portfolio and ranking #25.

Has Castleview Partners, LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), Castleview Partners, LLC increased its position in ELV. The position peaked in Q3 2025 at 6.64K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.